Integral Diagnostics Director’s Shareholding Increases

Integral Diagnostics Ltd. (AU:IDX) has released an update.

Integral Diagnostics Ltd. has reported a change in Director Ian Kadish’s interests, with a net increase of 26,035 fully paid ordinary shares after the vesting of FY23 STI Rights on August 30, 2024. The director now holds a total of 585,476 ordinary shares and 647,932 performance rights across various plans approved by shareholders. This change signifies an alignment of directorial interests with shareholder value, potentially impacting the company’s stock performance.

For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.